Core Viewpoint - The company is facing short-term performance pressure due to international trade fluctuations and industry cycle adjustments, but it is building long-term core competitiveness through global capacity layout, technology upgrades, and deepening quality tracks [1][2]. Financial Performance - In Q3 2025, the company's revenue was 91.61 million, a year-on-year decrease of 17.45%, and the net profit attributable to the parent company was 3.404 million, down 67.35%, with a notable decline in consumer electronics orders [2][4]. Strategic Initiatives - The company is establishing production capacity in Southeast Asia to address overseas clients' supply chain stability concerns, with plans to set up subsidiaries in Vietnam and Thailand [2][4]. - A supply chain management center has been established to optimize efficiency across procurement, logistics, and inventory management, addressing raw material procurement challenges [4]. Client Strategy - The company is focusing on a major client strategy, optimizing its client structure, and reducing reliance on single large clients while developing direct cooperation with high-quality clients [4][6]. - The company anticipates that new major clients will enter the top five list in the next 1-2 years, providing sustained growth momentum [4][6]. Core Business and Technology - The company integrates flexible circuit board (FPC) manufacturing with electronic assembly (SMT/SIP) capabilities, enhancing customer stickiness through a one-stop solution [5][8]. - The AI glasses segment is highlighted as a key business area, with the company becoming a core supplier for a major client and expanding its customer base [6][8]. Market Opportunities - The CCS integrated bus market is expected to grow significantly due to the expansion of the new energy vehicle industry, with the company already achieving mass production and securing orders from a major client [6][8]. - The medical electronics sector is projected to experience explosive growth, with the company focusing on customized FPC manufacturing and expanding into medical instruments [7][8]. Conclusion - The company is constructing a unique competitive barrier through its core manufacturing capabilities, which allows it to match technological demands with manufacturing strength, positioning itself for a new growth cycle as it overcomes short-term performance pressures [8].